NASDAQ: INDV - Indivior PLC

Rentabilidad a seis meses: -49.86%
Sector: Healthcare

Calendario de promoción Indivior PLC

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd.

Más detalles
The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

Цена ао 8.71
Выручка 0.785
EBITDA 0.23
Число акций ао 0.13653 млрд
P/E 0.5628
P/S 0.0961
P/BV 0.3608
ISIN GB00BN4HT335
Сайт https://www.indivior.com
Див.доход ао 12.24
Дивиденд ао 0.475
Валюта usd
IPO date 2014-12-29
Sector Health Care
Industry Biotechnology
Валюта отчета usd
EV/EBITDA -2.95
Cambio de precio por día: +0.1149% (8.7)
Cambio de precio por semana.: +10.25% (7.9)
Cambio de precio por mes: -8.12% (9.48)
Cambio de precio en 3 meses.: -19.94% (10.88)
Cambio de precio en seis meses: -49.86% (17.37)
Cambio de precio por año: -57.3% (20.4)
Cambio de precio en 3 años.: +1 309.39% (0.618)
Cambio de precio en 5 años.: +6 683.49% (0.1284)
Cambio de precio desde principios de año.: -48.21% (16.819)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 1.91 7
P/BV 58.87 1
P/E 1067.05 1
EV/EBITDA 7.17 9
Total: 5.88

Eficiencia

Nombre Significado Calificación
ROA, % 0.1025 1
ROE, % 2.95 1
Total: 3.5

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0.6667 6.67
Total: 4.22

Deber

Nombre Significado Calificación
Debt/EBITDA 0.8467 9
Total: 7.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 42.59 6
Rentabilidad Ebitda, % 27.34 4
Rentabilidad EPS, % -98.46 0
Total: 2
Más detalles

Instituciones Volumen Compartir, %
Two Seas Capital LP 13670312 9.96
Scopia Capital Management LP 8311367 6.06
Vanguard Group Inc 5846354 4.26
Goldman Sachs Group Inc 5683038 4.14
FMR, LLC 5498087 4.01
Artemis Investment Management LLP 3127399 2.28
Bank of America Corporation 2701855 1.97
Polar Capital Holdings PLC 2621150 1.91
Acadian Asset Management. LLC 2281179 1.66
Liontrust Investment Partners LLP 1995889 1.45

ETF Compartir, % Rentabilidad del año, % Dividendos, %
Avantis International Equity ETF 0.01813 16.593926168394 3.80856
Avantis International Small Cap Value ETF 0.03727 19.202975557917 4.23496
Dimensional International Core Equity Market ETF 0.00363 18.136311128225 3.48343
Dimensional World ex U.S. Core Equity 2 ETF 0.00881 17.752007136485 3.62488
Dimensional International Core Equity 2 ETF 0.00651 17.713295799047 3.69996
Dimensional International Small Cap ETF 0.03912 18.692449355433 3.34747
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.01806 12.945547945205 3.5165
Schwab International Small-Cap Equity ETF 0.05297 15.21998742929 3.20638
SPDR Portfolio Developed World ex-US ETF 0.00638 17.367399741268 3.28401
SPDR Portfolio Europe ETF 0.00943 14.447513812155 3.66537
SPDR Portfolio MSCI Global Stock Market ETF 0.00137 29.55850326668 2.19607
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.01219 20.01028227534 3.85434
Vanguard FTSE All-World ex-US Small-Cap ETF 0.05 14.41676965491 3.09932



Supervisor Título profesional Pago año de nacimiento
Mr. Mark Crossley CEO & Executive Director 2.34M
Mr. Ryan Preblick CFO & Executive Director 1.14M
Dr. Christian Heidbreder Chief Scientific Officer N/A
Mr. Jason Thompson Vice President of Investor Relations N/A
Ms. Cynthia Cetani Chief Integrity & Compliance Officer N/A
Mr. Jeffrey W. Burris Chief Legal Officer N/A 1972 (52 año)
Mr. Jon Fogle Chief Human Resources Officer N/A
Mr. Richard Simkin Chief Commercial Officer N/A
Mr. Hillel West Chief Manufacturing & Supply Officer N/A
Mr. Vishal Kalia SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer N/A

DIRECCIÓN: United States, North Chesterfield. VA, 10710 Midlothian Turnpike - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.indivior.com